Volume 15, Issue 5 (Sep-Oct 2021)                   mljgoums 2021, 15(5): 37-43 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahbazi M, Behpoor N, Faramarzi M, Banitalebi E. Effect of Moderate- and High-intensity Resistance Training on Some Serum Anabolic/Catabolic Osteokines in Old Male Wistar Rats. mljgoums. 2021; 15 (5) :37-43
URL: http://mlj.goums.ac.ir/article-1-1335-en.html
1- Department of Sport Sciences, Borujerd Branch, Islamic Azad University, Borujerd, Iran
2- Department of Sport Sciences, Borujerd Branch, Islamic Azad University, Borujerd, Iran and Faculty of Sport Sciences, Razi University, Kermanshah, Iran , n_behpoor@yahoo.com
3- Professor in Exercise Physiology, Faculty of Sport Sciences, Department of Exercise Physiology, University of Isfahan, Isfahan, Iran
4- Department of Sport Sciences, Shahrekord University, Iran
Abstract:   (272 Views)
Background and objectives: Bone-related osteokines play an important role in the response of bone metabolism to physical activity. The purpose of this study was to investigate effects of different intensities of resistance training on serum levels of some osteokines associated with the Wnt signaling pathway and receptor activator of nuclear factor kappa-Β ligand (RANKL) pathway in old male Wistar rats.
Methods: Twenty-four old (23 months) male Wistar rats (mean weight: 437.93±33 g) were randomly divided into three groups of moderate-intensity resistance training (n=8), high-intensity resistance training (n=8) and control (n=8). Moderate- and high-intensity resistance trainings were performed at 60% and 80% maximal voluntary carrying capacity, respectively. The level of wclerostin, osteoprotegerin (OPG) and RANKL was evaluated by enzyme linked immunosorbent assay. Data were analyzed using one-way analysis of variance and at significance level of ≤0.05.
Results: The results showed that sclerostin (p=0.014), OPG (p=0.049) and RANKL (P=0.034) differed significantly between the study groups. The Tukey post-hoc comparison showed that sclerostin decreased significantly in the high-intensity resistance training group  compared to moderate-intensity resistance training group (P=0.048). In addition, OPG decreased significantly in the moderate-intensity resistance training group compared to the control group (P=0.033). Moreover, RANKL decreased significantly in the high-intensity resistance training group compared to the control (P=0.048).
Conclusion: The results showed that resistance training with appropriate repetition and intensity can have positive effects on bone formation signaling pathways.
Full-Text [PDF 833 kb]   (136 Downloads) |   |   Full-Text (HTML)  (114 Views)  
Research Article: Original Paper | Subject: Sport Physiology
Received: 2020/10/1 | Accepted: 2021/02/7 | Published: 2021/08/31 | ePublished: 2021/08/31

References
1. Boskey AL, Coleman R. Aging and bone. Journal of dental research. 2010;89(12):1333-48. [View at Publisher] [DOI:10.1177/0022034510377791] [PubMed] [Google Scholar]
2. Tommasini SM, Nasser P, Jepsen KJ. Sexual dimorphism affects tibia size and shape but not tissue-level mechanical properties. Bone. 2007;40(2):498-505. [View at Publisher] [DOI:10.1016/j.bone.2006.08.012] [PubMed] [Google Scholar]
3. Bijeh N, Moazami M, Mansouri J, Saeedeh Nematpour F, Ejtehadi M. Effect of aerobic exercises on markers of bone metabolism in middle-aged women. Kowsar Medical Journal. 2011;16(2):129-35. [Google Scholar]
4. Lavigne G, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. Journal of oral rehabilitation. 2008;35(7):476-94. [View at Publisher] [DOI:10.1111/j.1365-2842.2008.01881.x] [PubMed] [Google Scholar]
5. Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S, et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. Journal of Bone and Mineral Research. 2006; 21(11): 1738-49. [View at Publisher] [DOI:10.1359/jbmr.060810] [PubMed] [Google Scholar]
6. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arteriosclerosis, thrombosis, and vascular biology. 2002; 22(4): 549-53. [View at Publisher] [DOI:10.1161/01.ATV.0000012303.37971.DA] [PubMed] [Google Scholar]
7. Niu T, Rosen CJ. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene. 2005;361:38-56. [View at Publisher] [DOI:10.1016/j.gene.2005.07.016] [PubMed] [Google Scholar]
8. Jilka RL, O'Brien CA. The role of osteocytes in age-related bone loss. Current osteoporosis reports. 2016;14(1):16-25. [View at Publisher] [DOI:10.1007/s11914-016-0297-0] [PubMed] [Google Scholar]
9. Brahm H, Piehl-Aulin K, Ljunghall S. Bone metabolism during exercise and recovery: the influence of plasma volume and physical fitness. Calcified tissue international. 1997;61(3):192-8. [View at Publisher] [DOI:10.1007/s002239900322] [PubMed] [Google Scholar]
10. Hinton PS, Rector RS, Thomas TR. Weight-bearing, aerobic exercise increases markers of bone formation during short-term weight loss in overweight and obese men and women. Metabolism. 2006;55(12):1616-8. [View at Publisher] [DOI:10.1016/j.metabol.2006.07.023] [PubMed] [Google Scholar]
11. Maddalozzo GF, Widrick JJ, Cardinal BJ, Winters-Stone KM, Hoffman MA, Snow CM. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women. Bone. 2007; 40(5): 1244-51. [View at Publisher] [DOI:10.1097/00005768-200305001-01566] [PubMed] [Google Scholar]
12. Bouassida A, Latiri I, Bouassida S, Zalleg D, Zaouali M, Feki Y, et al. Parathyroid hormone and physical exercise: a brief review. Journal of sports science & medicine. 2006; 5(3): 367. [View at Publisher] [PubMed] [Google Scholar]
13. Marques EA, Wanderley F, Machado L, Sousa F, Viana JL, Moreira-Gonçalves D, et al. Effects of resistance and aerobic exercise on physical function, bone mineral density, OPG and RANKL in older women. Experimental gerontology. 2011;46(7):524-32. [View at Publisher] [DOI:10.1016/j.exger.2011.02.005] [PubMed] [Google Scholar]
14. West SL, Scheid JL, De Souza MJ. The effect of exercise and estrogen on osteoprotegerin in premenopausal women. Bone. 2009;44(1):137-44. [View at Publisher] [DOI:10.1016/j.bone.2008.09.008] [PubMed] [Google Scholar]
15. Shimamura C, Iwamoto J, Takeda T, Ichimura S, Abe H, Toyama Y. Effect of decreased physical activity on bone mass in exercise-trained young rats. Journal of orthopaedic science. 2002;7(3):358-63. [View at Publisher] [DOI:10.1007/s007760200060] [Google Scholar]
16. Sinaki M, Wahner H, Bergstralh E, Hodgson S, Offord K, Squires R, et al. Three-year controlled, randomized trial of the effect of dose-specified loading and strengthening exercises on bone mineral density of spine and femur in nonathletic, physically active women. Bone. 1996;19(3):233-44. [View at Publisher] [DOI:10.1016/8756-3282(96)00174-3] [PubMed] [Google Scholar]
17. Pearson OM, Lieberman DE. The aging of Wolff's "law": ontogeny and responses to mechanical loading in cortical bone. American journal of physical anthropology. 2004;125(S39):63-99. [View at Publisher] [DOI:10.1002/ajpa.20155] [PubMed] [Google Scholar]
18. Aido MIFd. The influence of age and mechanical loading on bone structure and material properties: Technical University Berlin; 2015. [View at Publisher] [Google Scholar]
19. Trumbo P, Schlicker S, Yates AA, Poos M. Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002; 102(11): 1621-30. [PubMed] [Google Scholar]
20. Lombardi G, Sanchis-Gomar F, Perego S, Sansoni V, Banfi G. Implications of exercise-induced adipo-myokines in bone metabolism. Endocrine. 2016;54(2):284-305. [View at Publisher] [DOI:10.1007/s12020-015-0834-0] [PubMed] [Google Scholar]
21. Krug AL, Macedo AG, Zago AS, Rush JW, Santos CF, Amaral SL. High‐intensity resistance training attenuates dexamethasone‐induced muscle atrophy. Muscle & Nerve. 2016;53(5):779-88. [View at Publisher] [DOI:10.1002/mus.24906] [PubMed] [Google Scholar]
22. Macedo AG, Krug AL, Herrera NA, Zago AS, Rush JW, Amaral SL. Low-intensity resistance training attenuates dexamethasone-induced atrophy in the flexor hallucis longus muscle. The Journal of steroid biochemistry and molecular biology. 2014;143:357-64. [View at Publisher] [DOI:10.1016/j.jsbmb.2014.05.010] [PubMed] [Google Scholar]
23. Falk B, Haddad F, Klentrou P, Ward W, Kish K, Mezil Y, et al. Differential sclerostin and parathyroid hormone response to exercise in boys and men. Osteoporosis International. 2016;27(3):1245-9. [View at Publisher] [DOI:10.1007/s00198-015-3310-z] [PubMed] [Google Scholar]
24. Herrmann M, Herrmann W. The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers. Clinical Chemistry and Laboratory Medicine (CCLM). 2004;42(12):1384-9. [View at Publisher] [DOI:10.1515/CCLM.2004.258] [PubMed] [Google Scholar]
25. Khosla S. Minireview: The opg/rankl/rank system. Endocrinology. 2001;142(12):5050-5. [View at Publisher] [DOI:10.1210/endo.142.12.8536] [PubMed] [Google Scholar]
26. Mezil YA, Allison D, Kish K, Ditor D, Ward WE, Tsiani E, et al. Response of bone turnover markers and cytokines to high-intensity low-impact exercise. Med Sci Sports Exerc. 2015; 47(7): 1495-502. [View at Publisher] [DOI:10.1249/MSS.0000000000000555] [PubMed] [Google Scholar]
27. West DW, Burd NA, Staples AW, Phillips SM. Human exercise-mediated skeletal muscle hypertrophy is an intrinsic process. The international journal of biochemistry & cell biology. 2010; 42(9): 1371-5. [View at Publisher] [DOI:10.1016/j.biocel.2010.05.012] [PubMed] [Google Scholar]
28. Kish K, Mezil Y, Ward WE, Klentrou P, Falk B. Effects of plyometric exercise session on markers of bone turnover in boys and young men. European journal of applied physiology. 2015; 115(10): 2115-24. [View at Publisher] [DOI:10.1007/s00421-015-3191-z] [PubMed] [Google Scholar]
29. Bernstein CN, Sargent M, Leslie WD. Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study. Inflammatory bowel diseases. 2005;11(4):325-30. [View at Publisher] [DOI:10.1097/01.MIB.0000164015.60795.ca] [PubMed] [Google Scholar]
30. Oh KW, Rhee EJ, Lee WY, Kim SW, Baek KH, Kang MI, et al. Circulating osteoprotegerin and receptor activator of NF‐κB ligand system are associated with bone metabolism in middle‐aged males. Clinical endocrinology. 2005;62(1):92-8. [View at Publisher] [DOI:10.1111/j.1365-2265.2004.02179.x] [PubMed] [Google Scholar]
31. Bord S, Frith E, Ireland D, Scott M, Craig J, Compston J. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. British journal of haematology. 2004;126(2):244-51. [View at Publisher] [DOI:10.1111/j.1365-2141.2004.05024.x] [PubMed] [Google Scholar]
32. Banfi G, Corsi M, Galliera E. Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players. The Journal of Sports Medicine and Physical Fitness. 2012;52(2):198-201.
33. Sinha S, Eddington H, Kalra PA. Vascular calcification: lessons from scientific models. Journal of renal care. 2009;35:51-6. [View at Publisher] [DOI:10.1111/j.1755-6686.2009.00065.x] [PubMed] [Google Scholar]
34. Rubin J, Murphy TC, Zhu L, Roy E, Nanes MS, Fan X. Mechanical Strain Differentially Regulates Endothelial Nitric-oxide Synthase and Receptor Activator of Nuclear B Ligand Expression via ERK 1/2 MAPK. Journal of Biological Chemistry.278(36). [View at Publisher] [DOI:10.1074/jbc.M302822200] [Google Scholar]
35. Dekker J. The Effects of a Single Bout of Plyometric Exercise on Anabolic and Catabolic Osteokines in Girls and Adolescents. Broke University. 2016. [View at Publisher] [Google Scholar]
36. Kim JG, Kim JH, Lee DO, Kim H, Kim JY, Suh CS, et al. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor κB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. Menopause. 2008; 15(2): 357-62. [DOI:10.1097/gme.0b013e318133a153] [PubMed] [Google Scholar]
37. Liu J, Zhao H, Ning G, Zhao Y, Chen Y, Zhang Z, et al. Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75. Calcified Tissue International. 2005;76(1):1-6. [View at Publisher] [DOI:10.1007/s00223-004-0007-2] [PubMed] [Google Scholar]
38. Mödder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. Journal of bone and mineral research. 2011;26(2):373-9. [View at Publisher] [DOI:10.1002/jbmr.217] [PubMed] [Google Scholar]
39. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, et al. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. Journal of Bone and Mineral Research. 1999;14(4):518-27. [View at Publisher] [DOI:10.1359/jbmr.1999.14.4.518] [PubMed] [Google Scholar]
40. Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. The Journal of Clinical Endocrinology & Metabolism. 2010;95(5):2248-53. [View at Publisher] [DOI:10.1210/jc.2010-0067] [PubMed] [Google Scholar]
41. Ardawi M-SM, Rouzi AA, Qari MH. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. The Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3691-9. [View at Publisher] [DOI:10.1210/jc.2011-3361] [PubMed] [Google Scholar]
42. Spatz J, Fields E, Yu E, Pajevic PD, Bouxsein M, Sibonga J, et al. Serum sclerostin increases in healthy adult men during bed rest. The Journal of Clinical Endocrinology & Metabolism. 2012;97(9):E1736-E40. [View at Publisher] [DOI:10.1210/jc.2012-1579] [PubMed] [Google Scholar]
43. Lombardi G, Lanteri P, Colombini A, Mariotti M, Banfi G. Sclerostin concentrations in athletes: role of load and gender. Journal of biological regulators and homeostatic agents. 2012; 26(1): 157-63. [PubMed] [Google Scholar]
44. Sheng Z, Tong D, Ou Y, Zhang H, Zhang Z, Li S, et al. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clinical endocrinology. 2012;76(6):797-801. [View at Publisher] [DOI:10.1111/j.1365-2265.2011.04315.x] [PubMed] [Google Scholar]
45. Compton JT, Lee FY. A review of osteocyte function and the emerging importance of sclerostin. The Journal of bone and joint surgery American volume. 2014; 96(19): 1659. [View at Publisher] [DOI:10.2106/JBJS.M.01096] [PubMed] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.